Category

HIV Prevention

Key populations: policy development and partnerships the way forward

South Africa’s National Strategic Plan (2012-2016) highlights the need for policy development related to so-called ‘key populations’ which include men who have sex with men (MSM), sex workers and people who inject drugs, in order to ensure that our responses to the HIV pandemic are inclusive of these populations.

Mpumalanga Men’s Study

New study reveals exceptionally high HIV prevalence among men who have sex with men in Mpumalanga, indicating an urgent need to improve services.

According to the Mpumalanga Men’s Study, gay, bisexual and other men who have sex with men (MSM) in Mpumalanga are among the hardest hit by the HIV epidemic. HIV prevalence may be up to 30% among this high-risk group with large numbers of new infections occurring in the last 12 months.

Check your assumptions

We all make countless assumptions every day. We assume that in the morning the kettle and toaster will do their jobs, that the car will start or that our train will arrive at the station. We make assumptions about our partners, our family members, our colleagues and our friends, and about strangers. Our assumptions about our environment and the people around us are often based on nothing more than irrational notions, concepts, beliefs and attitudes which are very rarely based on fact.
Read more.

Truvada® approved by the FDA for the prevention of HIV

The latest milestone in the 30-year battle against HIV, is Monday’s approval of Truvada®  by the American Food and Drug Administration (FDA) for the prevention of HIV transmission. Truvada®  is the first anti-retroviral (ARV) drug to gain approval as a preventive measure for healthy HIV negative people who are at high risk of acquiring HIV through sexual activity, such as those who have HIV-infected partners.

Jury out on using ARV prophylaxis (Mail & Guardian)

South African guidelines for the preventative use of HIV medication by men who have sex with men who are not infected with the virus are to be published in the peer-reviewed academic publication, Southern African Journal of HIV Medicine, this month.

The treatment, pre-exposure prophylaxis (Prep), consists of an antiretroviral (ARV) pill that is taken daily by HIV-negative people to lower their chances of becoming infected with the virus.

Lubricants a potential risk factor

While consistent use of condoms remain your best defence against HIV and other sexually transmitted infection (STIs), evidence has emerged that some water-based lubricants may be harmful to your rectum. This applies equally to top-of-the-range, expensive imported brands and locally manufactured lubricants. 

These findings emerged when researchers trying to develop rectal microbicides started poking around and asking questions about the effects of sexual lubricants on the mucosal lining of the rectum

How does recreational drug use affect HIV?

Recreational drug use can make people more likely to be infected by HIV. Also, for people taking antiretroviral medications (ARVs) to fight HIV, there can be some serious interactions between drugs and ARVs. These interactions can lead to under- or overdoses of ARVs or recreational drugs. Some of these may be fatal.